- Home
- SHLS vs MANE Comparison
SHLS vs MANE Comparison
Compare SHLS & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SHLS | MANE |
|---|---|---|
| Founded | 1996 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | SHLS | MANE |
|---|---|---|
| Price | $10.54 | $91.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | $9.07 | ★ $83.33 |
| AVG Volume (30 Days) | ★ 5.1M | 398.1K |
| Earning Date | 05-05-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.86 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $475,331,000.00 | N/A |
| Revenue This Year | $26.24 | N/A |
| Revenue Next Year | $11.52 | N/A |
| P/E Ratio | $41.63 | ★ N/A |
| Revenue Growth | ★ 19.07 | N/A |
| 52 Week Low | $3.99 | $36.26 |
| 52 Week High | $13.18 | $117.71 |
Technical Indicators
Market Signals| Indicator | SHLS | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 52.53 | 43.33 |
| Support Level | $8.81 | $54.23 |
| Resistance Level | $11.27 | $107.95 |
| Average True Range (ATR) | 0.96 | 6.44 |
| MACD | -0.26 | -1.29 |
| Stochastic Oscillator | 36.54 | 18.00 |
Price Performance
Historical ComparisonAbout SHLS Shoals Technologies Group Inc.
Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.